Zoetis
Tablet 425 mg
Powder
WHOLE PANCREAS
NOT AN EXTRACT
NOT ENTERIC COATED
Each 425 mg tablet contains:
|
Lipase
|
9,000 USP units
|
|
Protease
|
57,000 USP units
|
|
Amylase
|
64,000 USP units
|
Each 2.8 grams (1 teaspoonful) of powder contains:
|
Lipase
|
71,400 USP units
|
|
Protease
|
388,000 USP units
|
|
Amylase
|
460,000 USP units
|
CAUTION
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
DESCRIPTION
VIOKASE-V is activated whole raw pancreas; a pancreatic enzyme concentrate of porcine origin containing standardized amylase, protease and lipase activities plus esterases, peptidases, nucleases and elastase.
INDICATIONS
As a digestive aid; replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.
PRECAUTIONS
Discontinue use in animals with symptoms of sensitivity.
ADMINISTRATION AND DOSAGE
The VIOKASE-V tablets are administered before each meal. VIOKASE-V powder is added to moistened dog food (canned or dry). Thorough mixing is necessary to bring the enzymes into close contact with the food particles. Incubation at room temperature for 15-20 minutes before feeding appears to enhance the digestive process. Frequent feeding, at least 3 times daily, is important.
USUAL DOSAGE
Dogs: 2-3 tablets or 3/4-1 teaspoonful (2.8 g/teaspoonful) with each meal.
Cats: 1/2-1 tablet or 1/4-3/4 teaspoonful (2.8 g/teaspoonful) with each meal.
NOTE: No one regimen will be successful for every patient. The above dosage should be adjusted according to the severity of the pancreatic exocrine deficiency and weight of the animal. In cases of chronic insufficiency, the dosage should be increased until desired results are obtained.
Each tablet contains sufficient pancreatic enzymes to digest (in vitro): 33 g fat, 57 g protein, 64 g starch.
Each 2.8 grams (1 teaspoonful) contains sufficient pancreatic enzymes to digest (in vitro): 260 g fat, 388 g protein, 460 g starch.
